Trial Profile
A Phase IV Multicentre, Randomised, Double-Blind, Placebo Controlled, Trial to Evaluate the Safety and Efficacy of Raptiva in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis Involving Hands and/or Feet, With or Without Pustules.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2021
Price :
$35
*
At a glance
- Drugs Efalizumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms TRUST
- Sponsors Merck Serono
- 05 Oct 2021 According to Eudra the trail has been completed in France.
- 04 Sep 2021 This trial has been completed in Spain, according to European Clinical Trials Database.
- 28 Jun 2012 Additional trial locations added as reported by European Clinical Trials Database.